These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9126691)

  • 1. Penetration of meropenem in plasma and abdominal tissues from patients undergoing intraabdominal surgery.
    Condon RE; Walker AP; Hanna CB; Greenberg RN; Broom A; Pitkin D
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S181-3. PubMed ID: 9126691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue penetration of Meropenem in patients undergoing gynecologic surgery.
    Gall S; Hemsell DL; McGregor JA; Martens MG; Pitkin D; Allen S
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S178-80. PubMed ID: 9126690
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peritoneal pharmacokinetics and pharmacodynamic target attainment of meropenem in patients undergoing abdominal surgery.
    Soga Y; Ohge H; Ikawa K; Morikawa N; Ikeda K; Sueda T
    J Chemother; 2010 Apr; 22(2):98-102. PubMed ID: 20435568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacology of meropenem, a new carbapenem antibiotic.
    Craig WA
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S266-75. PubMed ID: 9126702
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population Pharmacokinetics and Target Attainment of Meropenem in Plasma and Tissue of Morbidly Obese Patients after Laparoscopic Intraperitoneal Surgery.
    Wittau M; Scheele J; Kurlbaum M; Brockschmidt C; Wolf AM; Hemper E; Henne-Bruns D; Bulitta JB
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6241-7. PubMed ID: 26248353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of Meropenem for Use in Bacterial Keratitis.
    Sueke H; Kaye S; Wilkinson MC; Kennedy S; Kearns V; Zheng Y; Roberts P; Tuft S; Neal T
    Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5731-8. PubMed ID: 26325409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meropenem: a new carbapenem antimicrobial.
    Pryka RD; Haig GM
    Ann Pharmacother; 1994 Sep; 28(9):1045-54. PubMed ID: 7803882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biapenem.
    Perry CM; Ibbotson T
    Drugs; 2002; 62(15):2221-34; discussion 2235. PubMed ID: 12381221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo antibacterial activities of meropenem, a new carbapenem antibiotic.
    Harabe E; Kawai Y; Kanazawa K; Otsuki M; Nishino T
    Drugs Exp Clin Res; 1992; 18(2):37-46. PubMed ID: 1644010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Meropenem: an updated review of its use in the management of intra-abdominal infections.
    Lowe MN; Lamb HM
    Drugs; 2000 Sep; 60(3):619-46. PubMed ID: 11030471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Meropenem Penetration into Cerebrospinal Fluid in Patients with Meningitis After Neurosurgery.
    Zhang Y; Zhang J; Chen Y; Yu J; Cao G; Wu X; Chen M; Wu J; Zhao X
    World Neurosurg; 2017 Feb; 98():525-531. PubMed ID: 27867128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacokinetics of meropenem in pancreatic juice and site-specific pharmacodynamic target attainment against Gram-negative bacteria: dosing considerations.
    Kondo N; Ikawa K; Murakami Y; Uemura K; Sudo T; Hashimoto Y; Ohge H; Morikawa N; Sueda T
    Pancreatology; 2014; 14(2):95-9. PubMed ID: 24650961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of borneol on the concentration of meropenem in rat brain and blood.
    Xin HL; He XR; Li W; Zhou ZD; Zhang S; Wang GJ
    J Asian Nat Prod Res; 2014; 16(6):648-57. PubMed ID: 24827508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative pharmacokinetics and pharmacodynamics of doripenem and meropenem in obese patients.
    Kays MB; Fleming MR; Cheatham SC; Chung EK; Juenke JM
    Ann Pharmacother; 2014 Feb; 48(2):178-86. PubMed ID: 24259653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the susceptibility trends to meropenem in a nationwide collection of clinical isolates in Japan: a longitudinal analysis from 2002 to 2006.
    Ishii Y; Yamaguchi K;
    Diagn Microbiol Infect Dis; 2008 Jul; 61(3):346-50. PubMed ID: 18339507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A study of the penetration of meropenem into bile using endoscopic retrograde cholangiography.
    Granai F; Smart HL; Triger DR
    J Antimicrob Chemother; 1992 Jun; 29(6):711-8. PubMed ID: 1506351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Preclinical evaluation of meropenem, a new parenteral carbapenem].
    Edwards JR
    New Microbiol; 1995 Oct; 18 Suppl():19S-31S. PubMed ID: 8574929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activity of meropenem versus other extended-spectrum antimicrobials against randomly chosen and selected resistant clinical isolates tested in 26 North American centers.
    Pitkin DH; Sheikh W; Nadler HL
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S238-48. PubMed ID: 9126699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [In vitro antibacterial activity of meropenem, a new carbapenem: European data].
    Debbia EA; Marchese A; Pesce A; Schito GC
    New Microbiol; 1995 Oct; 18 Suppl():1S-17S. PubMed ID: 8574928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of meropenem in the treatment of serious infections in children: review of the current literature.
    Arrieta A
    Clin Infect Dis; 1997 Feb; 24 Suppl 2():S207-12. PubMed ID: 9126695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.